The accurate, easy-to-deploy HRD test for labs | Datasheet English
The HRD test is a key biomarker to identify ovarian cancer patients likely to respond to PARP inhibitor (PARPi) therapy.
SeqOne offers a clinically validated HRD test designed specifically for efficient deployment in labs that want to deliver HRD tests in-house while offering following benefits:
- Clinically validated performance on PAOLA-1
- 95% concordance with reference test
- Quality control statistics
- Easy to deploy in any lab